Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Public ClinicalTrials.gov record NCT02330965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)
Study identification
- NCT ID
- NCT02330965
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Interventions
- Blood Draw Procedure
- CSF collection by lumbar puncture (Optional) Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Jul 11, 2017
- Completion
- Jul 11, 2017
- Last update posted
- Nov 8, 2020
2014 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jordan Research & Education Institute: Sutter Alta Bates Summit | Berkeley | California | 94705 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of California, Davis | Sacramento | California | 95817 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| University of Michigan Health System -Multiple Sclerosis Center | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | — |
| University of New Mexico: Health Sciences Center | Albuquerque | New Mexico | 87131 | — |
| South Shore Neurologic Associates - Multiple Sclerosis Care Center | Patchogue | New York | 11772 | — |
| Carolinas Medical Center (CMC) | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic: Mellen Center for Multiple Sclerosis | Cleveland | Ohio | 44195 | — |
| Providence Multiple Sclerosis Center | Portland | Oregon | 97225 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02330965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2020 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02330965 live on ClinicalTrials.gov.